TesoRx Pharma
A clinical-stage pharmaceutical company, TesoRx Pharma develops therapeutics using an advanced oral drug delivery platform, including its candidate TSX-049.
Secondary Market Price
How TesoRx Pharma Measures Up
To help you manage your TesoRx Pharma equity, Prospect has run the company through our machine learning model.
Prospect Rating
--
This rating reflects our belief in this company's potential to grow to that many times its current value in 4 years. For an employee with stock, this rating suggests a potential return on equity, but it also comes with some risk.
Exit Risk
--
Our rating is a reflection of the likelihood of this company achieving a liquidity event for its employees based on the quality of investors, funding stage, founders, and more.
Funding Stage
Series B-1
A company’s funding stage reflects how established it is, how quickly it is scaling, and the average impact an employee may have when joining.
Secondary Market Price Chart
Create a free account to unlock real-time secondary market prices and future projections of TesoRx Pharma's value.
Sign up to Unlock the Latest DataData will be available soon.
Sign up to receive notifications when it is available.
Prospect Projected Future TesoRx Pharma Prices
Prospect’s machine learning model has been trained on the same data top-tier investors use to project the likely range of outcomes for TesoRx Pharma's equity. Create a free account to view 10th-90th percentile projections over 2, 4, and 6 years.
Powerful tools to earn more from your equity
Company Description
TesoRx Pharma is a clinical-stage pharmaceutical company based in Menlo Park, California. The company is focused on developing new products for medical conditions with limited or suboptimal treatment options, utilizing an advanced oral drug delivery platform. Its current activities include research and development, with products such as TSX-049 undergoing clinical studies. Details regarding the company's history and founding are not available in the provided source materials.
TesoRx is working to expand its product portfolio and advance its oral drug delivery technology for new therapeutics. The company's future plans center on the continued development of its product pipeline and conducting clinical trials. The provided information does not contain any specific recent announcements.
- Aspen Pharmacare Holdings
- ASKA Pharmaceutical Co., Ltd.
- All Care Group
- Co-Founder, Ramachandran "TR" Thirucote
- Co-Founder, Guru Betageri
- Co-Founder, Willem A. Robberts
- Co-Founder, Michael Oefelein
Peer Group Comparison
Vs Peer Group of >$4B Startups
Frequently Asked Questions
Joining Anduril as an employee is another way to acquire equity, typically through stock options included in compensation packages.
Is TesoRx Pharma worth joining?
Deciding to join a startup like TesoRx Pharma requires evaluating the total compensation package, where equity can be a significant component. Tools like Prospect can help you model the potential financial outcomes of your equity grant to make a more informed decision.
What should I do with my TesoRx Pharma stock?
Managing your TesoRx Pharma stock effectively requires a personalized strategy that accounts for your financial goals, the company's performance, and complex tax implications. Platforms like Prospect build custom, multi-year plans for exercising options and selling shares to help maximize your take-home value.
Can you sell TesoRx Pharma stock?
As TesoRx Pharma is a private company, selling stock is typically restricted to company-approved events like tender offers or secondary market sales. When these opportunities arise, Prospect’s Tender Offer Tools can help you determine how much to sell and which shares are the most tax-optimal.
How can I find the value of my TesoRx Pharma stock?
The value of private stock is based on the company's latest 409A valuation and any available secondary market data, which can be difficult to access. Prospect uses proprietary predictive models trained on venture capital data to help you forecast your equity's potential future value.
What is TesoRx Pharma's equity worth?
The exact worth of your equity in a private company like TesoRx Pharma depends on your specific grant, the company's current valuation, and its future prospects. To understand its potential post-tax value, you can use platforms like Prospect to generate customized financial models and exercise strategies.
What is TesoRx Pharma's stock ticker symbol?
TesoRx Pharma does not have a stock ticker symbol because it is a private company whose shares are not traded on public stock exchanges. Ticker symbols are only assigned to companies after they complete an Initial Public Offering (IPO).
Can I buy or sell TesoRx Pharma stock?
Since TesoRx Pharma is a private company, opportunities to buy stock are typically limited to employees exercising options or accredited investors in specific funding rounds. Selling is also restricted to company-approved windows, and a platform like Prospect can help you create a tax-optimized strategy for when you are able to sell.
What is the criteria to buy or invest in TesoRx Pharma stock?
Investing in a private company like TesoRx Pharma is generally restricted to employees receiving equity compensation or accredited investors who are invited to participate in private funding rounds. These investment opportunities are not available to the general public before the company holds an IPO.
